We are live on ! Find out more
MBII

Marrone Bio Innovations, Inc.

Delisted

MBII was delisted on the 12th of July, 2022.

63 hedge funds and large institutions have $191M invested in Marrone Bio Innovations, Inc. in 2014 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 33 increasing their positions, 7 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

375% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 4

371% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 7

38% more call options, than puts

Call options by funds: $66K | Put options by funds: $48K

31% more funds holding

Funds holding: 4863 (+15)

30% more capital invested

Capital invested by funds: $146M → $191M (+$44.5M)

Holders
63
Holders Change
+15
Holders Change %
+31.25%
% of All Funds
1.81%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
19
Increased
33
Reduced
7
Closed
4
Calls
$66K
Puts
$48K
Net Calls
+$18K
Net Calls Change
+$18K
Name Holding Trade Value Shares
Change
Change in
Stake
CBOA
26
Commonwealth Bank of Australia
Australia
$584K +$569K +50,223 New
GH
27
GAM Holding
Switzerland
$569K +$79.3K +7,000 +17%
TCIM
28
TIAA CREF Investment Management
New York
$503K +$342K +30,221 +232%
Morgan Stanley
29
Morgan Stanley
New York
$425K +$5.95K +525 +1%
BCM
30
Bridgeway Capital Management
Texas
$407K
BIM
31
BlackRock Investment Management
Delaware
$374K +$174K +15,328 +91%
COPPSERS
32
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$318K +$57.3K +5,058 +23%
Tudor Investment Corp
33
Tudor Investment Corp
Connecticut
$295K +$288K +25,391 New
EEG
34
E.E. Geduld
$291K +$113K +10,000 +67%
California Public Employees Retirement System
35
California Public Employees Retirement System
California
$272K +$18.9K +1,671 +8%
California State Teachers Retirement System (CalSTRS)
36
California State Teachers Retirement System (CalSTRS)
California
$241K +$124K +10,900 +111%
Jane Street
37
Jane Street
New York
$225K +$220K +19,398 New
Charles Schwab
38
Charles Schwab
California
$196K +$190K +16,800 New
ACM
39
Archon Capital Management
Washington
$180K +$176K +15,500 New
CIA
40
Capital Impact Advisors
Massachusetts
$175K +$171K +15,079 New
TA
41
Teachers Advisors
New York
$169K +$106K +9,392 +183%
RFS
42
Rockefeller Financial Services
New York
$167K
PP
43
PDT Partners
New York
$162K +$158K +13,945 New
Millennium Management
44
Millennium Management
New York
$147K -$189K -16,691 -57%
Goldman Sachs
45
Goldman Sachs
New York
$145K +$142K +12,511 New
LPL Financial
46
LPL Financial
California
$131K -$187K -16,500 -59%
Susquehanna International Group
47
Susquehanna International Group
Pennsylvania
$120K +$117K +10,294 New
NFA
48
Nationwide Fund Advisors
Ohio
$99K +$49.1K +4,334 +104%
AIG
49
American International Group
New York
$86K +$33.8K +2,986 +68%
BA
50
BlackRock Advisors
Delaware
$56K +$21.6K +1,907 +65%

MBII Hedge Fund Activity: Q2 2014 in Review

63 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in Marrone Bio Innovations, Inc. (MBII) for Q2 2014, worth a combined $191M — up 30% from $146M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new MBII positions and 4 closed out — a net gain of 15 holders — while 33 added to existing stakes and 7 trimmed.

The largest buyer was Waddell & Reed Financial, adding an estimated $33.8M. The largest seller was Gilder Gagnon Howe & Co, cutting an estimated $12.3M.

  • 63 institutional investors held Marrone Bio Innovations, Inc. (MBII) as of Q2 2014, up from 48 in Q1 2014.
  • Funds reported $191M of Marrone Bio Innovations, Inc. stock for Q2 2014, up 30% quarter-over-quarter.
  • 19 funds opened new Marrone Bio Innovations, Inc. positions in Q2 2014 and 4 closed out, a net change of +15 holders.
  • The largest Marrone Bio Innovations, Inc. buyer in Q2 2014 was Waddell & Reed Financial, an estimated $33.8M added.
  • The largest Marrone Bio Innovations, Inc. seller in Q2 2014 was Gilder Gagnon Howe & Co, an estimated $12.3M sold.

Based on aggregated 13F filings for Q2 2014.